Compare Summit Therapeutics Inc (SMMT) vs Skyworks Solutions Inc (SWKS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Summit Therapeutics Inc vs Skyworks Solutions Inc — how do they compare? Summit Therapeutics Inc trades at $14.58 (market cap $10.48B), while Skyworks Solutions Inc trades at $62.99 (market cap $8.99B). The key difference: Summit Therapeutics Inc is the larger of the two by market cap, and Skyworks Solutions Inc pays a 4.75% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| SMMT | SWKS | |
|---|---|---|
Market Cap | $10.48B | $8.99B |
Sector | Health | Technology |
52-Week High | $29.32 | $83.40 |
52-Week Low | $13.05 | $52.50 |
Enterprise Value | $9.90B | $8.76B |
Dividend Yield | — | 4.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Skyworks Solutions (SWKS) trades at $62.95, up 6.14% on the day, with a bearish technical signal but strong fundamental valuation metrics including a P/E of 24.91 and P/S of 2.22. The company has beaten earnings estimates for three consecutive quarters, with Q2 2026 results pending. Recent news highlights ongoing investigations into corporate governance alongside positive coverage of its EV and AI semiconductor innovations.
The stock presents a mixed outlook: analyst consensus is bullish with a $75.88 price target (35 Buy, 23 Hold, 2 Sell), but risks include declining revenue trends (2025: $4.09B, 2026 est: $4.0B), margin compression, and legal scrutiny. Near-term catalysts depend on Q2 earnings beat potential and EV/AI segment growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →About Skyworks Solutions Inc
Skyworks Solutions produces semiconductors for wireless handsets and other devices that are used to enable wireless connectivity. Its main products include power amplifiers, filters, switches, and integrated front-end modules that support wireless transmissions. Skyworks' customers are mostly large smartphone manufacturers, but the firm also has a growing presence in nonhandset applications such as wireless routers, medical devices, and automobiles.
Read more on SWKS →
